Michael E. Williams
Abstract
ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, dacarbazine) chemotherapy is a standard regimen for treating patients with Hodgkin lymphoma
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
ABVD (doxorubicin [Adriamycin], bleomycin, vinblastine, dacarbazine) chemotherapy is a standard regimen for treating patients with Hodgkin lymphoma
Key concepts: Medicine, ABVD, Neutropenia, Hodgkin lymphoma, Lymphoma, Intensive care medicine, Internal medicine, Oncology